Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates intercellular adhesion molecule-1 and cytokine-induced neutrophil chemoattractant-1 expression...

Por Liu, D, Zeng, B, Zhang, S, Geng, Z
Publicado em 2005

Dose-dependent effects of selenite (Se(4+)) on arsenite (As(3+))-induced apoptosis and differentiation in acute promyelocytic leukemia cells

Por Wang, S, Geng, Z, Shi, N, Li, X, Wang, Z
Publicado no Cell Death Dis (2015)

Protective effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on endotoxin-induced acute lung injury in rats

Por Liu, D, Zeng, B, Zhang, S, Wang, Y, Zeng, L, Geng, Z
Publicado em 2005

Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials

Por van der Zee, H.H., Longcore, M., Geng, Z., Garg, A.
Publicado no J Eur Acad Dermatol Venereol (2019)

Modulators for Terahertz Communication: The Current State of the Art

Por Ma, Z. T., Geng, Z. X., Fan, Z. Y., Liu, J., Chen, H. D.
Publicado no Research (Wash D C) (2019)

Diffusion-weighted imaging to differentiate metastatic from non-metastatic retropharyngeal lymph nodes in nasopharyngeal carcinoma

Por Li, H, Liu, X-W, Geng, Z-J, Wang, D-L, Xie, C-M
Publicado no Dentomaxillofac Radiol (2015)

Dietary resveratrol supplementation prevents transport-stress-impaired meat quality of broilers through maintaining muscle energy metabolism and antioxidant status

Por Zhang, C., Wang, L., Zhao, X. H., Chen, X. Y., Yang, L., Geng, Z. Y.
Publicado no Poult Sci (2017)

Effects of intracutaneous injections of sterile water in patients with acute low back pain: a randomized, controlled, clinical trial

Por Cui, J.Z., Geng, Z.S., Zhang, Y.H., Feng, J.Y., Zhu, P., Zhang, X.B.
Publicado no Braz J Med Biol Res (2016)

Optomechanically-induced transparency in parity-time-symmetric microresonators

Por Jing, H., Özdemir, Şahin K., Geng, Z., Zhang, Jing, Lü, Xin-You, Peng, Bo, Yang, Lan, Nori, Franco
Publicado no Sci Rep (2015)

Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase‐3, randomized, placebo‐controlled trial

Por Elewski, B.E., Baker, C.S., Crowley, J.J., Poulin, Y., Okun, M.M., Calimlim, B., Geng, Z., Reyes Servin, O., Rich, P.A.
Publicado no J Eur Acad Dermatol Venereol (2019)

Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials

Por Jemec, G.B.E., Okun, M.M., Forman, S.B., Gulliver, W.P.F., Prens, E.P., Mrowietz, U., Armstrong, A.W., Geng, Z., Gu, Y., Williams, D.A., Teixeira, H.D., Kimball, A.B.
Publicado no Br J Dermatol (2019)

Genetic relationship of populations in China

Por Chu, J. Y., Huang, W., Kuang, S. Q., Wang, J. M., Xu, J. J., Chu, Z. T., Yang, Z. Q., Lin, K. Q., Li, P., Wu, M., Geng, Z. C., Tan, C. C., Du, R. F., Jin, L.
Publicado em 1998

CD4(+)CD45RB(Hi) T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin

Por Byrne, F R, Morony, S, Warmington, K, Geng, Z, Brown, H L, Flores, S A, Fiorino, M, Yin, S L, Hill, D, Porkess, V, Duryea, D, Pretorius, J K, Adamu, S, Manuokian, R, Danilenko, D M, Sarosi, I, Lacey, D L, Kostenuik, P J, Senaldi, G
Publicado em 2005